DREAM研究中抑郁与干眼症状、体征及炎症标志物严重程度的关联
该研究基于DREAM随机临床试验的535例中重度干眼患者数据,进行横断面和纵向二次分析,发现抑郁筛查阳性与更严重的干眼症状(OSDI效应量0.45,P<.001;BODI效应量0.46,P<.001)和复合体征评分(效应量0.21,P=.006)相关,而炎症标志物无差异。
要点
- 抑郁筛查阳性的干眼患者OSDI和BODI症状评分更差,复合体征评分也更高。
- 基线、6个月和12个月时,MCS评分越低(抑郁越重)与OSDI评分越高(干眼症状越重)相关。
- 炎症标志物(泪液细胞因子和结膜HLA-DR表达)在抑郁与非抑郁患者间无差异。
核心结论
- 抑郁与更严重的干眼症状和总体体征相关,提示中重度干眼患者中抑郁者可能干眼更严重。
- 这些发现支持在管理干眼患者时将抑郁视为共病考虑,需进一步研究阐明两者关系。
研究设计与样本
- 对DREAM随机临床试验数据进行的二次横断面和纵向分析,分析于2020年4月至12月进行,试验于2014年10月至2016年7月开展。
- 纳入27个眼科和验光中心(学术和私立机构)、17个美国州的中重度干眼症状和体征患者535例,随访1年。
- 抑郁筛查阳性定义为36项简短健康调查心理成分总结(MCS)评分≤42分。
主要发现
- 535例参与者平均(SD)年龄58(13.2)岁,434例(81%)为女性,398例(74.4%)为白人。
- 抑郁筛查阳性者OSDI症状更差(效应量=0.45,P<.001),BODI更差(效应量=0.46,P<.001),复合干眼体征评分更高(效应量=0.21,P=.006)。
- MCS评分越低(抑郁越重)与OSDI评分越高(干眼症状越重)相关:基线Spearman ρ=-0.09,P=.03;6个月ρ=-0.20,P<.001;12个月ρ=-0.21,P<.001。
- 炎症标志物在抑郁状态间无差异。
关键数值与推荐
- 抑郁筛查阳性:MCS评分≤42分。
- 干眼症状评估:OSDI和BODI;体征评估:泪膜破裂时间、Schirmer试验、角膜和结膜染色、泪液渗透压、睑板腺功能障碍,并计算6项体征的复合严重程度评分。
临床怎么用
- 作者认为,管理干眼患者时可将抑郁视为共病考虑。
- 原文未据此给出具体治疗推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Depression is more prevalent in patients with dry eye disease (DED) than in the general population; however, the association between severity of DED and depression needs further evaluation. OBJECTIVE: To investigate the association between depression and severity of DED symptoms and signs, including inflammatory markers. DESIGN, SETTING, AND PARTICIPANTS: Secondary cross-sectional and longitudinal analysis performed in April to December 2020 of data from Dry Eye Assessment and Management (DREAM) study, a randomized clinical trial from October 2014 to July 2016 including patients with moderate to severe symptoms and signs of DED. Enrolled from 27 ophthalmology and optometry centers, both academic and private, in 17 US states, 535 patients were followed up for 1 year. EXPOSURE: Participants screened positive for depression if they scored 42 or less on the Mental Component Summary (MCS) of the 36-Item Short Form Health Survey. MAIN OUTCOMES AND MEASURES: Symptoms of DED were assessed by Ocular Surface Disease Index (OSDI) and Brief Ocular Discomfort Index (BODI) and signs assessed by tear film breakup time, Schirmer test, corneal and conjunctival staining, tear osmolarity, and meibomian gland dysfunction at baseline, 6 months, and 12 months. A composite severity sign score was calculated from all 6 signs. Inflammatory markers (cytokines in tears and HLA-DR expression by conjunctival surface cells) were measured for some trial participants. Features of DED were compared between participants with and without depression and adjusted for age, sex, race, visits, and baseline comorbidities. RESULTS: Among the 535 participants, mean (SD) age was 58 (13.2) years, 434 participants (81%) were women, and 398 (74.4%) were White. Participants who screened positive for depression had worse DED symptoms by OSDI (effect size = 0.45, P < .001) and BODI (effect size = 0.46, P < .001) and composite DED sign score (effect size = 0.21, P = .006). Lower MCS score (ie, worse depression) was correlated with higher OSDI score (ie, worse DED symptoms) at baseline (Spearman ρ = -0.09, P = .03), 6 months (ρ = -0.20, P < .001), and 12 months (ρ = -0.21, P < .001). Inflammatory markers did not differ by depression status. CONCLUSIONS AND RELEVANCE: Depression was associated with more severe dry eye symptoms and overall signs, suggesting that among patients with moderate to severe DED, those with depression may be likely to have more severe DED. These findings support consideration of depression as a comorbidity when managing patients with DED. Further study is needed to elucidate the relationship.
引用
- Zhou Y, Murrough J, Yu Y, et al. Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study. JAMA Ophthalmol. 2022. PMID: 35266971. doi:10.1001/jamaophthalmol.2022.0140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。